###begin article-title 0
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
Characterization of two functional NKX3.1 binding sites upstream of the PCAN1 gene that are involved in the positive regulation of PCAN1 gene transcription
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 252 258 252 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 434 440 434 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 500 506 500 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
NKX3.1 and PCAN1 are both prostate-specific genes related to prostate development and prostate cancer. So far, little is known about the regulatory mechanisms of the expression of these two genes. In the present study, we found that NKX3.1 upregulated PCAN1 gene transcription in LNCaP prostate cancer cells. To understand the regulatory mechanisms, our work focused on identifying the functional NKX3.1 binding sites upstream of the PCAN1 gene, which might be involved in the positive regulation of PCAN1 expression by NKX3.1.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 437 443 437 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 521 528 521 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 557 563 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 574 580 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 646 653 646 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 862 868 862 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 968 969 968 969 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1013 1020 1013 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 1104 1110 1104 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 1169 1175 1169 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 640 645 <span type="species:ncbi:9606">human</span>
We cloned and characterized a 2.6 kb fragment upstream of the PCAN1 gene. Analysis of the 2.6 kb sequence with MatInspector 2.2 revealed five potential binding sites of NKX3.1 transcription factor. Luciferase reporter assays, electrophoretic mobility shift assays, chromatin immunoprecipitation and RNA interference were performed to study the effects of NKX3.1 on PCAN1 gene expression in prostate cancer cells. Our results showed that PCAN1 promoter activity and mRNA expression were increased by transfection with the NKX3.1 containing plasmid (pcDNA3.1-NKX3.1) and that PCAN1 mRNA expression was decreased by RNA interference targeting human NKX3.1 in LNCaP prostate cancer cells. The results of electrophoretic mobility shift assays and chromatin immunoprecipitation showed that NKX3.1 bound to NBS1 (-1848 to -1836) and NBS3 (-803 to -791) upstream of the PCAN1 gene. The luciferase reporter assays showed that NBS1 and NBS3 enhanced the promoter activity in pGL3-promoter vector with cotransfection of the NKX3.1 containing plasmid. Furthermore, the deletion of NBS1 or both NBS1 and NBS3 reduced PCAN1 promoter activity and abolished the positive regulation of PCAN1 expression by NKX3.1.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 122 128 122 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
Our results suggested that two functional NKX3.1 binding sites located at -1848 to -1836 and -803 to -791 upstream of the PCAN1 gene were involved in the positive regulation of PCAN1 gene transcription by NKX3.1.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 62 65 <span type="species:ncbi:9606">men</span>
###xml 124 127 <span type="species:ncbi:9606">men</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
Prostate cancer is the most frequently diagnosed neoplasia in men and one of the leading causes of cancer-related deaths in men over 60 [1]. Although early prostate specific antigen (PSA) detection and surgery have decreased the death rate, most of the patients still die of metastasis and recurrence of prostate cancer [2,3]. However, the mechanisms involved in the onset and progression of prostate cancer are poorly understood at the molecular level. It is important to understand the molecular biology of this cancer for its prevention, early diagnosis, and effective treatment.
###end p 9
###begin p 10
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GDEP</italic>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 150 156 150 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
PCAN1 (prostate cancer gene 1, also known as GDEP) is highly expressed in prostate epithelial tissue and frequently mutated in prostate tumors [4-6]. PCAN1 expression is undetectable in the highly undifferentiated DU145 and PC-3 prostate cancer cell lines and weakly detected in the more differentiated LNCaP cell line [5]. This gene is localized to chromosome 4q21, a region of the genome that experiences frequent loss of heterozygosity (LOH) in prostate cancer. It is mutated in 35% of the tumor samples [5]. Therefore,PCAN1 has been proposed to have tumor suppressing function in prostate cancer.
###end p 10
###begin p 11
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 152 159 152 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx3.1 </italic>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 380 387 380 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx3.1 </italic>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 563 570 563 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx3.1 </italic>
###xml 646 653 646 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 910 919 910 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink"> in vitro</italic>
###xml 947 954 947 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 533 539 <span type="species:ncbi:9606">humans</span>
###xml 640 645 <span type="species:ncbi:9606">Human</span>
###xml 672 677 <span type="species:ncbi:9606">human</span>
###xml 744 749 <span type="species:ncbi:9606">human</span>
NKX3.1 is a prostate-specific homeobox gene that is thought to play an important role in the normal development of prostate and carcinogenesis. In mice Nkx3.1 is exclusively expressed in prostate epithelium [7,8]. Its targeted disruption leads to aberrations in prostate ductal morphogenesis and secretory protein production, and epithelial hyperplasia and dysplasia [9]. Notably Nkx3.1 mutant mice display the pathologic changes of prostatic intraepithelial neoplasia (PIN) [10] that is the presumed precursor to prostate cancer in humans, implying that loss of Nkx3.1 expression correlates with the initiation of prostate carcinogenesis. Human NKX3.1 has been mapped to human chromosome 8p21, a region with frequent loss of heterozygosity in human prostate cancer [11]. This gene has been proposed to have tumor suppressing function [12]. It also inhibits the growth of cultured prostate cancer cells [13-15] in vitro. The strong association of NKX3.1 with prostate development and prostate cancer makes this gene an attractive molecular target for further study.
###end p 11
###begin p 12
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 332 338 332 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 592 620 592 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1, p53, Sp1, cEBP&#945; </italic>
###xml 624 634 620 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPAR&#947; </italic>
###xml 683 689 675 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 734 740 726 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 829 835 821 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 935 941 927 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 987 993 979 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 1061 1067 1053 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 1136 1142 1128 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
NKX3.1 and PCAN1 are both prostate-specific genes strongly related to prostate development and prostate cancer. Studying the regulatory mechanisms of their expression is important for understanding their roles in prostate development and prostate cancer. In this study, we cloned and characterized a 2.6 kb fragment upstream of the PCAN1 gene. Analysis of the 2.6 kb sequence with MatInspector 2.2 revealed potential binding sites of some important transcription factors, including NKX3.1, P53, Sp1, cEBP and PPAR/RXR heterodimers. In our study, the eukaryotic expression plasmids containing NKX3.1, p53, Sp1, cEBPalpha and PPARgamma were respectively used to study their effects on PCAN1 expression. We found that NKX3.1 upregulated PCAN1 promoter activity and mRNA expression. To explore the regulatory mechanisms of NKX3.1 on PCAN1 transcription, we focused on identifying the functional NKX3.1 binding sites (NBSs) upstream of the PCAN1 gene. We demonstrated that NKX3.1 upregulated PCAN1 gene transcription through direct binding with NBSs upstream of the PCAN1 gene. Our study provided a molecular mechanism for the regulation of PCAN1 gene expression.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
Effects of NKX3.1 on PCAN1 promoter activity and mRNA expression
###end title 14
###begin p 15
###xml 71 77 71 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 207 208 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 209 210 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 268 274 268 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 367 373 367 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 460 461 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 462 463 462 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 482 488 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 535 536 535 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 537 538 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 574 580 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 717 724 717 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 754 760 754 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 805 806 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
In our previous work, a 2.6 kb promoter fragment (+32 to -2598) of the PCAN1 gene amplified by PCR was inserted into pGL3-basic vector to form the PCAN1 promoter-luciferase reporter plasmid designated as pGL3-pPCAN1. Firefly luciferase expression driven by the 2.6 kb PCAN1 promoter was used to evaluate the promoter activity [16]. To detect the effects of NKX3.1 on PCAN1 gene expression, LNCaP and PC-3 cells were harvested 48 h after cotransfection with pGL3-pPCAN1 and pcDNA3.1-NKX3.1. The control cells were cotransfected with pGL3-pPCAN1 and pcDNA3.1 (+) plasmid. The PCAN1 promoter activity detected by dual-luciferase reporter assays was enhanced by 1.6-fold in LNCaP cells and by 1.8-fold in PC-3 cells with NKX3.1 cotransfection, compared with PCAN1 promoter activity in the control cells (Fig. 1).
###end p 15
###begin p 16
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of NKX3.1 on the <italic>PCAN1 </italic>promoter in LNCaP and PC-3 cells</bold>
###xml 113 114 113 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 135 142 135 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 200 201 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 511 512 509 510 <bold xmlns:xlink="http://www.w3.org/1999/xlink">*</bold>
###xml 512 514 510 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 522 526 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">**p </italic>
###xml 543 546 541 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
Effects of NKX3.1 on the PCAN1 promoter in LNCaP and PC-3 cells. LNCaP and PC-3 cells were cotransfected with pGL3-pPCAN1 and pcDNA3.1-NKX3.1 (grey bars). The control cells were cotransfected with pGL3-pPCAN1 and pcDNA3.1 (+) plasmid (blank bars). The cells were harvested 48 h after transfection and PCAN1 promoter activity was detected by dual-luciferase reporter assays. Results were expressed as relative luciferase activities (M1/M2). The data were represented as the mean of four individual values +/- SD.*p < 0.05, **p < 0.05, grey bar vs blank bar.
###end p 16
###begin p 17
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 225 231 225 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
The PCAN1 mRNA expression level in LNCaP cells, as detected by RT-PCR, was increased significantly by NKX3.1 cotransfection, compared with that of the control cells transfected with pcDNA3.1 (+) plasmid (Fig. 2A and 2B). The PCAN1 mRNA expression level in PC-3 cells was undetectable by RT-PCR (Fig. 2A and 2B).
###end p 17
###begin p 18
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of NKX3.1 on <italic>PCAN1 </italic>mRNA expression in LNCaP and PC-3 cells</bold>
###xml 93 99 93 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 138 141 138 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 218 224 218 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 300 306 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 328 331 328 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 402 409 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 412 418 412 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 421 432 421 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 490 493 485 488 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 581 588 576 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 630 633 625 628 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D. </bold>
###xml 633 640 628 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 644 650 639 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 747 753 742 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 741 746 <span type="species:ncbi:9606">human</span>
Effects of NKX3.1 on PCAN1 mRNA expression in LNCaP and PC-3 cells. The effects of NKX3.1 on PCAN1 mRNA expression as detected by RT-PCR. A. PCAN1 mRNA expression following transfection of LNCaP cells with 1. pcDNA3.1-NKX3.1; 2. pcDNA3.1 (+); or following transfection of PC-3 cells with 3. pcDNA3.1-NKX3.1; or 4. pcDNA3.1 (+). B. Relative expression levels were presented as the ratio of densities of NKX3.1 or PCAN1 to beta-actin bands. The results were expressed as mean +/- SD (n = 3). C. The expression of NKX3.1 protein in LNCaP and PC-3 cells after transfection of pcDNA3.1-NKX3.1 (1, 3, 5, 7) or pcDNA3.1 (+) (2, 4, 6, 8).D. NKX3.1 and PCAN1 mRNA expression following stable transfection of LNCaP cells with 1. pRNAT-RNAi1 targeting human NKX3.1; 2. pRNAT-RiN as a control vector.
###end p 18
###begin p 19
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
The expression of endogenous NKX3.1 in LNCaP cells was knocked down by RNAi, which made the PCAN1 mRNA expression decrease, as detected by RT-PCR (Fig. 2D).
###end p 19
###begin title 20
Identification of specific NKX3.1 binding sites (NBSs) with nuclear extracts
###end title 20
###begin p 21
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 952 954 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
Analysis of the 2.6 kb promoter sequence with MatInspector 2.2 revealed five potential NKX3.1 transcription factor binding sites (sequences are shown in Fig. 3A). They were located at -1848 to -1836 (NBS1), -1080 to 1068 (NBS2), -803 to -791 (NBS3), -179 to 166 (NBS4) and -131 to -119 (NBS5), upstream of the PCAN1 gene. To investigate the binding activities of these five NBSs with NKX3.1 transcription factor, we carried out electrophoretic mobility shift assays (EMSA). It was performed with NKX3.1-transfected nuclear extracts from LNCaP cells and synthesized oligonucleotide probes containing these five NBS sequences. The results showed that DNA-protein binding complexes were identified for the NBS1 probe and the NBS3 probe (Fig 3B). The bindings of NBS1 and NBS3 with nuclear extracts proved to be specific, as they were blocked by a 250-fold excess of unlabeled NBS1 probe (Fig. 3C) or NBS3 probe (Fig. 3D) and by anti-NKX3.1 antibody (Fig. 3C and 3D), but not by unlabeled mutant NBS1 probe or mutant NBS3 probe (Fig. 3C and 3D).
###end p 21
###begin p 22
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Binding assays of NKX3.1 binding sites with nuclear extracts</bold>
###xml 62 65 62 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 163 166 163 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 484 486 484 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 489 493 489 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink"> D. </bold>
Binding assays of NKX3.1 binding sites with nuclear extracts. A. Locations and sequences of five potential NKX3.1 binding sites (NBSs) upstream of the PCAN1 gene. B. EMSA was performed to assay the binding activities of the five NBSs with the nuclear extracts from LNCaP cells. 1-5: labelled NBS1~NBS5 with LNCaP nuclear extracts respectively. A DNA-protein binding complex was formed when the labelled probe of NBS1 (lane 1) or NBS3 (lane 3) was reacted with LNCaP nuclear extracts. C and D. Competition binding and antibody blocking were used to detect the specific binding of the NBS1 (C) or NBS3 (D) with NKX3.1. Labelled NBS1 or NBS3 without nuclear extracts was used as the control (lane1); a specific DNA-protein complex was formed when labelled NBS1 or NBS3 was reacted with LNCaP nuclear extracts (lane 2). Competition binding was performed in the presence of a 250-fold molar excess of unlabelled NBS1 or NBS3 (lane 3), unlabelled mutant NBS1 or NBS3 (lane 4). The binding activity of probe NBS1 or NBS3 to nuclear extracts could be blocked by anti-NKX3.1 antibody (lane5).
###end p 22
###begin title 23
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
NKX3.1 binds to NBS1 and NBS3 upstream of the PCAN1 gene in living cells
###end title 23
###begin p 24
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 552 558 552 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 867 873 867 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 387 393 <span type="species:ncbi:9986">rabbit</span>
###xml 769 775 <span type="species:ncbi:9986">rabbit</span>
To determine whether NKX3.1 also binds to the NBSs in vivo, we performed chromatin immunoprecipitation (ChIP) assays, which are used to define interactions of proteins with specific DNA elements in living cells. ChIP was carried out in LNCaP cells transfected with pcDNA3.1-NKX3.1. After cross-linking with formaldehyde, cell lysates were immunoprecipitated with anti-NKX3.1 antibody or rabbit IgG (negative control). The DNA purified from this coprecipitation was analyzed by PCR with primers (sequences are shown in Table 1) spanning the NBSs in the PCAN1 promoter. As shown in Fig. 4, we observed a clear PCR product using NBS1 primer or NBS3 primer but no band was observed using NBS2 primer or NBS4,5 primer, and no PCR product was identified for all primers with rabbit IgG precipitation complexes, indicating that NKX3.1 bound to NBS1 and NBS3 upstream of the PCAN1 gene in living cells.
###end p 24
###begin p 25
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 binds to the NBSs of the <italic>PCAN1 </italic>promoter in living cells</bold>
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 350 356 350 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 256 262 <span type="species:ncbi:9986">rabbit</span>
NKX3.1 binds to the NBSs of the PCAN1 promoter in living cells. LNCaP cells transfected with pcDNA3.1-NKX3.1 were cross-linked by formaldehyde treatment and lysed. Cell lysates were subjected to immunoprecipitation with either an antibody to NKX3.1 (A) or rabbit IgG (B). Four primers (names and sequences are shown in Table 1) spanning five NBSs of PCAN1 promoter region were used for PCR of recovered DNA from the immunoprecipitation (lanes 2-5). Input DNA was used as positive control (C).
###end p 25
###begin p 26
PCR primers used in chromatin immunoprecipitation
###end p 26
###begin p 27
NBS1 F and R span NBS1;
###end p 27
###begin p 28
NBS2 F and R span NBS2; NBS3 F and R span NBS3; BNS4,5 F and R span NBS4 and NBS5
###end p 28
###begin title 29
###xml 92 96 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Interaction of NKX3.1 with NBS1 or NBS3 stimulates luciferase reporter expression driven by SV40 promoter
###end title 29
###begin p 30
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 94 95 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 187 194 187 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 369 376 369 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 709 712 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 722 730 722 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 419 423 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 622 626 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
To investigate the interactions between NKX3.1 and these five potential NBSs in vivo, five pGL3-NBS-promoter luciferase plasmids were constructed (Fig. 5) and cotransfected with pcDNA3.1-NKX3.1 plasmid respectively into LNCaP cells, while the control cells were cotransfected with pcDNA3.1 (+) vector. The luciferase reporter assays showed that when cotransfected with NKX3.1 expression plasmid, NBS1 and NBS3 enhanced SV40 promoter activity by 1.7-fold and 2.1-fold, respectively, compared with that of the control cells that were cotransfected with pcDNA3.1 (+) vector. NBS2, NBS4, NBS5 showed no significant effects on SV40 promoter activity. These results suggested that NBS1 and NBS3 were the functional cis-elements in vivo for the upregulation by NKX3.1.
###end p 30
###begin p 31
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of NBSs on the SV40 heterogeneous promoter</bold>
###xml 96 105 96 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 154 155 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 239 240 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 269 270 269 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 325 332 325 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 448 449 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 717 719 715 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 726 730 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">**p </italic>
###xml 748 751 746 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
###xml 23 27 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 134 138 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 398 402 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Effects of NBSs on the SV40 heterogeneous promoter. The sequences of five NBSs were synthesized in vitro and inserted upstream of the SV40 promoter in pGL3-promoter vector generating the pGL3-NBS-promoter plasmids. The five recombinant pGL3-NBS-promoter plasmids or pGL3-promoter vector were then cotransfected with pcDNA3.1-NKX3.1 respectively, to study the effects of NBSs on the activity of the SV40 heterogeneous promoter. Cotransfection of pGL3-NBS-promoter with pcDNA3.1 (+) vector was used as the control. The promoter activities were determined by dual luciferase assays. Results were expressed as relative luciferase activity (M1/M2). The data were represented as the mean of four individual values +/- SD. *p < 0.01,**p < 0.01, strip bar vs blank bar.
###end p 31
###begin title 32
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
Deletion of NBS1 and NBS3 in the PCAN1 promoter abolishes the positive regulation by NKX3.1
###end title 32
###begin p 33
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 44 53 44 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 279 280 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 331 337 331 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 411 412 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 420 421 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 454 455 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 548 549 548 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 550 551 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 586 593 586 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 707 714 707 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 733 739 733 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 809 815 809 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 836 839 836 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 896 902 896 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
The binding assays of five NBSs in vivo and in vitro suggested that NBS1 and NBS3 in the PCAN1 promoter were involved in the positive regulation of PCAN1 expression by NKX3.1. To further confirm this observation, the sequences of NBS1, or both NBS1 and NBS3 were deleted from pGL3-pPCAN1 to examine the effects of the deletions on PCAN1 promoter activity. The results in Fig. 6 showed that deletion of NBS1 (pGL3-NBS1id-pPCAN1) or both NBS1 and NBS3 (pGL3-NBS1,3idd-pPCAN1) reduced the promoter activity to 75% or 50% of the wild-type promoter (pGL3-pPCAN1). With cotransfection of the NKX3.1 expression plasmid, deletion of NBS1 partially abolished, and deletion of both NBS1 and NBS3 completely abolished NKX3.1 stimulation of the PCAN1 promoter. These findings suggested that NBS1 and NBS3 upstream of the PCAN1 gene were functional cis-elements mediating the positive regulation by NKX3.1 of PCAN1 gene transcription.
###end p 33
###begin p 34
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effects of deletion of NBS1 and NBS3 on <italic>PCAN1 </italic>promoter activity</bold>
###xml 68 69 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 70 71 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 183 184 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 230 236 230 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 249 250 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 274 275 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 344 350 344 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 398 405 398 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 683 685 681 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 695 697 693 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 714 717 712 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs </italic>
Effects of deletion of NBS1 and NBS3 on PCAN1 promoter activity. pGL3-pPCAN1 is a luciferase reporter plasmid containing a 2.6 kb wild type PCAN1 promoter; pGL3-NBS-Id represented pGL3-NBS1id-pPCAN1 with deletion of NBS1 from the PCAN1 promoter; pGL3-NBS-Idd represented pGL3-NBS1,3idd-pPCAN1, in which both NBS1 and NBS3 were deleted from the PCAN1 promoter. They were cotransfected with pcDNA3.1-NKX3.1 (grey bar) or pcDNA3.1 (+) vector (blank bar) into LNCaP cells, and the promoter activity was analyzed by dual-luciferase reporter assays. Results were expressed as relative luciferase activities (M1/M2). The data were represented as the mean of four individual values +/- SD. *p < 0.01, **p < 0.05, grey bar vs blank bar.
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 208 215 208 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 693 700 693 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx3.1 </italic>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 755 762 755 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx3.1 </italic>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 948 954 948 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx3.1</italic>
###xml 954 957 954 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 963 969 963 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx3.1</italic>
###xml 969 973 969 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1131 1138 1131 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 1172 1178 1172 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 1281 1287 1281 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
###xml 1055 1060 <span type="species:ncbi:9606">human</span>
NKX3.1 is a prostate-specific homeobox gene that is thought to play important roles in normal prostate development. NKX3.1 protein has been proposed to act as a specific tumor suppressor in prostate. Loss of NKX3.1 expression correlates with prostate carcinogenesis [15] and prostate tumor progression [17]. It was reported that NKX3.1 could collaborate with other transcription factors, such as serum response factor (SRF) [18], Sp-family protein [19] and prostate derived Ets factor (PDEF) [20], to regulate the expression of target genes. The potential for NKX3.1 to exert a differentiating and growth suppressing effect on prostatic epithelium was confirmed by targeted gene disruption of Nkx3.1 in mice [21]. Deletion of either one or both copies of Nkx3.1 resulted in prostatic epithelial hyperplasia and dysplasia that increased in severity with age. Magee et al. [21] has analyzed the expression profiles of prostate tissues from wild-type,Nkx3.1+/-, and Nkx3.1-/- mice and identified Nkx3.1 target genes. However, the genes directly regulated by human NKX3.1 have yet to be identified. In the present study, we found that NKX3.1 upregulated the expression of the PCAN1 gene in LNCaP prostate cancer cells and identified two functional NKX3.1 binding sites upstream of the PCAN1 gene.
###end p 36
###begin p 37
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 581 587 581 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 941 947 941 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 1214 1220 1214 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 1240 1246 1240 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 1384 1391 1384 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 1394 1400 1394 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
PCAN1 is highly expressed in prostate epithelial tissue and was initially identified in a screen for prostate-specific genes. As an important gene in prostate cancer initiation or progression [22], it has been shown that PCAN1 is frequently mutated or deleted in prostate tumor samples [5] and differentially expressed in tumor versus normal prostate tissue, demonstrating a prostate tumor suppressor role [6]. So far, little is known about the regulatory mechanisms of PCAN1 gene expression as well as the relevant regulatory elements and factors. Cross et al. [4] has identified PCAN1 gene in prostate epithelial tissue and demonstrated its expression pattern in different cells. They did an initial characterization of 2.5 kb sequence upstream of the initiation sites with the MatInspector program, in which they found several important transcription factor binding sites, including NKX3.1 binding sites. In our study, we cloned a 2.6 kb PCAN1 promoter sequence and five NKX3.1 binding sites were found in this region with the MatInspector (core/matrix sim: 0.75/optimized). We further performed reporter assays, RNAi, EMSA and ChIP to demonstrate that NKX3.1 could directly bind to NKX3.1 binding sites in the PCAN1 promoter to enhance PCAN1 gene expression in prostate cancer cells. This finding provides a foundation for future studies of the regulatory mechanisms and roles of NKX3.1 on PCAN1 gene expression in prostate development and prostate cancer.
###end p 37
###begin p 38
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 420 426 420 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 620 627 620 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 879 886 879 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 988 995 988 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 1211 1218 1211 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 1383 1389 1383 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 1465 1472 1465 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 1476 1482 1476 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 1550 1556 1550 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
NKX3.1 is proposed to be a nuclear transcriptional factor. It preferentially binds the TAAGTA sequence [23] to regulate its target gene expression. It is reported that NKX3.1 acts as a transcription factor through recruitment of some corepressors [24,25] or coactivators [26,27] to repress or activate its target genes. Our study provided some evidences to show that NKX3.1 directly binds to NKX3.1 binding sites in the PCAN1 promoter to activate PCAN1 gene expression in prostate cancer cells. However, further studies will be required to explore the regulatory mechanisms and the cofactors involved in the regulation. NKX3.1 is a prostate-specific gene required for maintenance of the normal differentiated state of the prostate epithelium. It is proposed to have tumor suppressing function. However, it is not a classic tumor suppressor gene. Despite that loss of function of NKX3.1 predisposes to prostate cancer, it is not sufficient for tumorigenesis. Moreover, while one allele of NKX3.1 is lost by means of chromosomal deletion in prostate cancer, the other allele does not undergo mutational inactivation. These features are not consistent with activities of "classic" tumor suppressor genes. Instead, NKX3.1 appears to act more like a tumor modulator, serving as a regulator of differentiation, which in turn prevents cancer initiation. Our finding that NKX3.1 upregulates PCAN1 expression will give a clue for further exploring the relationships between NKX3.1 and PCAN1 and understanding the functional importance of NXK3.1 in regulating PCAN1 in prostate differentiation and carcinogenesis. Identification of the specific biological functions of NKX3.1 in prostate cancer may provide targets for the early diagnosis and prevention of prostate cancer.
###end p 38
###begin p 39
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 126 132 126 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 262 268 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 272 279 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 339 341 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-8</sup>
###xml 344 348 344 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-10 </sup>
###xml 361 368 361 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 414 420 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 483 489 483 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 637 643 637 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 719 725 719 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 766 773 766 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 827 832 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1</italic>
###xml 847 849 847 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AR</italic>
###xml 851 858 851 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 862 868 862 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
NKX3.1 is an androgen regulated gene and its expression is upregulated by androgens. It is presumed that androgens upregulate PCAN1 expression through increasing NKX3.1 expression. In the experiments we have analyzed the effect of androgen (R1881) on endogenous PCAN1 and NKX3.1 expression in LNCaP cells. Our results showed that R1881 (10-8~10-10 M) increased NKX3.1 expression but have no significant effects on PCAN1 expression in RT-PCR (results are not shown in this paper) and PCAN1 promoter activity in luciferase reporter assays (results are shown in our paper in Cell Mol Biol Lett). So far, it is not very clear whether or not PCAN1 gene expression is regulated directly by androgens. It may be possible that PCAN1 is negatively regulated by androgens and NKX3.1 compensates this effect through positively regulating PCAN1. In addition, AR, NKX3.1 and PCAN1 play different roles in prostate development and cancer, and their interactions in prostate are very complicated and need further to be investigated.
###end p 39
###begin title 40
Conclusion
###end title 40
###begin p 41
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 236 243 236 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 398 404 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
In conclusion, we cloned and characterized the human PCAN1 promoter, and identified two functional NKX3.1 binding sites upstream of the PCAN1 gene, which were involved in the positive regulation by NKX3.1 of PCAN1 gene expression. Both NKX3.1 and PCAN1 are related to prostate development and prostate cancer. Our findings will contribute to the understanding of molecular regulatory mechanisms of PCAN1 gene expression in prostate development and cancer.
###end p 41
###begin title 42
Methods
###end title 42
###begin title 43
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
Construction of the NKX3.1 eukaryotic expression plasmid (pcDNA3.1-NKX3.1)
###end title 43
###begin p 44
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR </italic>
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 234 241 234 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR </italic>
###xml 573 579 573 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 624 630 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR </italic>
###xml 734 738 734 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not </italic>
###xml 797 804 797 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 115 119 <span type="species:ncbi:162683">Mayo</span>
###xml 511 515 <span type="species:ncbi:9913">calf</span>
pCR2.1-NKX3.1, a T-clone of NKX3.1 cDNA containing the complete sequence of NKX3.1 (a gift from Dr. Charles Young, Mayo Clinics, USA), was digested with EcoR I (TakaRa, Shiga, Japan) to release the 971 bp fragment of NKX3.1 cDNA. The NKX3.1 cDNA sequence (971 bp) contains the CDS of NKX3.1 including a start codon, a stop codon and a partial 3' UTR. It was then inserted into pcDNA3.1 (+) vector (Invitrogen Life Technologies, San Diego, CA, USA), which had been digested with EcoR I and dephosphorylated with calf intestine alkaline phosphatase (TaKaRa), to generate the NKX3.1-cDNA eukaryotic expression plasmid pcDNA3.1-NKX3.1. The recombinant plasmid was digested with EcoR I to identify the size of the insert and digested with Not I (TaKaRa) to identify the correct insert orientation. The NKX3.1 cDNA was also confirmed by DNA sequencing.
###end p 44
###begin title 45
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Construction of the PCAN1 promoter-luciferase reporter plasmid (pGL3-pPCAN1)
###end title 45
###begin p 46
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
###xml 158 164 158 164 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TAGCTA</underline>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe </italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
###xml 236 242 236 242 <underline xmlns:xlink="http://www.w3.org/1999/xlink">AAGCTT</underline>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind </italic>
###xml 578 582 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe </italic>
###xml 588 593 570 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind </italic>
###xml 655 656 637 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 717 718 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 719 720 701 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 89 94 <span type="species:ncbi:9606">human</span>
The 2.6 kb promoter fragment (+32 to -2598) of the PCAN1 gene was amplified by PCR using human genomic DNA as the template. The primer pairs were PCANF 5'-CCCTAGCTAGCCATCTCTGCAGTCTCGAC-3' with a Nhe I site at the 5'-end and PCANR 5'-CCCAAGCTTCGCTCTGACTTCCTCTTC-3' with a Hind III site at the 5'-end. The PCR was conducted at 96degreesC for 2 min followed by 35 cycles at 98degreesC for 20 s, 68degreesC for 10 min. The amplified fragment was isolated and purified following agarose electrophoresis using a Gel Extract Kit (Omega Bil-Tek. Inc. Doraville, GA, USA), digested with Nhe I and Hind III (TaKaRa), and ligated into the equivalent sites of the pGL3-basic vector (Promega, Madison, WI, USA) to generate the pGL3-pPCAN1 construct. The resulting construct was confirmed by restriction enzyme digestion and DNA sequence analysis.
###end p 46
###begin title 47
Construction of luciferase reporter plasmids of NKX3.1 binding sites (pGL3-NBS-promoter)
###end title 47
###begin p 48
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlu </italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho </italic>
###xml 434 435 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-</italic>
###xml 706 707 700 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 682 686 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 777 781 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Analysis of the 2.6 kb promoter sequence using MatInspector 2.2 revealed five potential binding sites for the NKX3.1 transcription factor. To confirm the functional binding sites, we synthesized oligonucleotides corresponding to these five sequences (NBS1~NBS5) shown in Table 2. Each NBS sequence was synthesized with an overhanging Mlu I site (CGCGT) at the 5'-end of the sense strand and an overhanging Xho I site (TCGAG) at the 5'-end of the antisense strand. The double-stranded NBS was generated by annealing equal amounts of sense and antisense oligonucleotides at 95degreesC for 10 min, then cooling to room temperature. The double-stranded NBS was inserted upstream of the SV40 promoter in the pGL3-promoter (Promega) vector to generate the recombinant plasmid of NBS-SV40 promoter-luciferase reporter gene. All constructs were confirmed by DNA sequencing.
###end p 48
###begin p 49
Probes used in electrophoretic mobility shift assays
###end p 49
###begin title 50
Construction of the NBS deletion plasmids of pGL3-pPCAN1
###end title 50
###begin p 51
###xml 125 126 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 186 187 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
###xml 683 687 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
###xml 693 697 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
###xml 813 817 777 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
###xml 823 827 787 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
###xml 927 928 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 959 964 911 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind </italic>
###xml 972 976 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe </italic>
###xml 1015 1016 967 968 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1024 1025 976 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1075 1076 1027 1028 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1088 1089 1040 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1151 1152 1103 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1160 1161 1112 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1270 1274 1222 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
###xml 1330 1334 1282 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN</italic>
The construction of NBS1 or both NBS1 and NBS3 deletion plasmids was made by a two-step PCR procedure. In the first step, pGL3-pPCAN1 was used as the template for the construction of pGL3-NBS1id-pPCAN1, and two PCR fragments were generated with two primer pairs, NBS1id-up 5'-CCCTGACTTGGGGGGCTCC ACTGTAGTAC-3' and PCANF 5'-CCCTAGCTAGCCATCTCTGCAGTCTCGAC-3', NBS1id-down 5'-TGGAGCCCCCCAAGTCAGGGGGTTTAATC-3' and PCANR 5'-CCCAAGCTTCGCTCTGACTTCCTCTTC-3'. The PCR conditions were 94degreesC for 2 min, 98degreesC for 10 s, 68degreesC for 5 min, 32 cycles. The two PCR fragments were purified by agarose electrophoresis and used together as templates in the second step of PCR with primers PCANF and PCANR. The PCR conditions were 94degreesC for 2 min, 60degreesC for 30 s, 72degreesC for 5 min, followed by addition of PCANF and PCANR primers and PCR at 98degreesC for 10 s, 68degreesC for 6 min, 32 cycles. The PCR fragments and pGL3-basic were both digested with Hind III and Nhe I and ligated together to construct pGL3-NBS1id-pPCAN1. A similar approach was used to generate pGL3-NBS1, 3idd-pPCAN1, in which both NBS1 and NBS3 sequences were deleted. pGL3-NBS1id-pPCAN1 was used as the template and other two primer pairs, NBS3id-up 5'-GAATGCCTGGTATTTCTTATCAAGAGAAC-3' and PCANF, NBS3id-down 5'-ATAAGAAATACCAGGCATTCCCTTCCACCA-3' and PCANR, were used. The constructed deletion plasmids were validated by DNA sequencing.
###end p 51
###begin title 52
Cell culture
###end title 52
###begin p 53
###xml 154 156 148 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 233 239 <span type="species:ncbi:9913">bovine</span>
The human prostate cancer cell lines LNCaP and PC-3 were obtained from the American Type Culture Collection (ATCC). They were grown at 37degreesC in 5% CO2 with RPMI 1640 media (Sigma, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (Gibco, BRL Grand Island, NK, USA), ampicillin 100 U/ml and streptomycin 100 U/ml.
###end p 53
###begin title 54
Transient transfection
###end title 54
###begin p 55
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 178 180 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 198 199 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 200 201 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
For the promoter activity assay of pGL3-pPCAN1, LNCaP and PC-3 cells were transfected with lipofectamintrade mark 2000 (Invitrogen) in 24-well plates. Each well included 1.5 x 105 cells, 1.0 mug pGL3-pPCAN1, 0.04 mug internal control vector pRL-TK (Promega), 2 mul lipofectamintrade mark 2000 and 500 mul RPMI 1640 media without serum and antibiotics. The cells were analyzed using a dual-luciferase reporter assay system (Promega) 48 h after completion of the transfection procedure.
###end p 55
###begin p 56
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 90 91 90 91 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 106 107 106 107 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 147 148 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 160 161 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 293 295 284 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 313 314 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 343 349 332 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
For cotransfection experiments of the NKX3.1 expression plasmid (pcDNA3.1-NKX3.1) with pGL3-construct (pGL3-pPCAN1, pGL3-NBS-promoter, pGL3-NBS1id-pPCAN1 or pGL3-NBS1,3idd-pPCAN1), LNCaP cells were transfected with lipofectamintrade mark 2000 in 24-well plates, and each well included 1.5 x 105 cells, 0.8 mug pGL3-construct, 0.4 mug pcDNA3.1-NKX3.1, 0.04 mug pRL-TK, 2 mul lipofectamintrade mark 2000 and 500 mul RPMI 1640 media without serum and antibiotics.
###end p 56
###begin title 57
Dual-luciferase reporter assays
###end title 57
###begin p 58
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 672 673 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Forty-eight hours after the transfection, the activities of Firefly luciferase in pGL3-constructs and Renilla luciferase in pRL-TK were determined by the dual-luciferase reporter assays following the protocol of the manufacture (Promega). The cells were rinsed with phosphate-buffered saline, and lysed with 1 x passive lysis buffer. Twenty mul of cell lysate was transferred into the luminometer tube containing 100 mul luciferase assay reagent II. Firefly luciferase activity (M1) was measured first, and then Renilla luciferase activity (M2) was determined after the addition of 100 mul Stop & Glo reagent. M1/M2 was taken as the relative luciferase activity of the pGL3-constructs.
###end p 58
###begin title 59
Reverse transcription-PCR
###end title 59
###begin p 60
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 287 293 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN-</italic>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN-</italic>
###xml 371 378 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3,1 </italic>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX</italic>
###xml 418 421 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX</italic>
###xml 456 467 456 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 528 534 525 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 567 577 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin</italic>
###xml 606 616 600 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin</italic>
###xml 726 731 699 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1</italic>
###xml 753 759 720 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 791 796 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1</italic>
###xml 812 818 773 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
Total RNA was isolated from LNCaP and PC-3 cells using Trizol reagent (Invitrogen) 48 h after transfection with pcDNA3.1-NKX3.1, and expression of PCAN1 mRNA was determined by RT-PCR with M-MuL V reverse transcriptase (Promega) in the presence of random hexamer primers. PCR primers for PCAN1 were PCAN-F 5'-GCGATGTGCTGTGAAATCTA-3', PCAN-R 5'-CTTTCACATTCCCCGTGGT-3'; for NKX3,1 were NKX-F 5'-GTACCTGTCGGCCCCTGAACG-3', NKX-R 5'-GCTGTTATACACGGAGACCAGG-3'. A beta-actin mRNA was amplified and used to normalize the quantity of the PCAN1 mRNA in RT-PCR. The primers were beta-actinF 5'-GCTGTCAGAGTGGTTATGT-3', beta-actinR 5'-ACATTGACGTACAGAG AGAG-3'. The PCR conditions were 94degreesC 3 min, 94degreesC 30 s, 56degreesC 30 s for PCAN1, 63degreesC 30 s for NKX3.1, 72degreesC 50s, 32 cycles for PCAN1, 26 cycles for NKX3.1, 72degreesC 6 min. The products were identified by 1.5% agarose gel electrophoresis.
###end p 60
###begin title 61
Western blot analysis of NKX3.1 protein expression
###end title 61
###begin p 62
###xml 288 295 287 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 789 800 787 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 597 603 <span type="species:ncbi:9986">rabbit</span>
###xml 609 614 <span type="species:ncbi:9606">human</span>
###xml 686 690 <span type="species:ncbi:9925">goat</span>
###xml 696 702 <span type="species:ncbi:9986">rabbit</span>
Expression of NKX3.1 in prostate cancer cells was analyzed by Western blot analysis. Briefly, total protein was extracted from PC-3 cells or LNCaP cells using lysis buffer (containing 50 mM Tris-Cl, pH 8.0, 150 mM NaCl, 0.1%SDS, 1%NP-40, 100 mug/ml PMSF) after transfection with pcDNA3.1-NKX3.1 for 48 h to 72 h. The protein content of the samples was measured using the BCA protein assay kit (Shenergy Biocolor Bioscience & Technology Company, Shanghai, China). Thirty mug of each protein sample was used to detect the NKX3.1 protein expression by Western blot analysis. The primary antibody was rabbit anti-human NKX3.1 (RDI, Concord MA, USA) diluted 1: 2000; the second antibody was goat anti-rabbit IgG (Sigma) diluted 1: 2000. Relative protein levels were calculated in comparison to beta-actin as standard. Immunoblots were detected using an ECL kit (Santa Cruz, CA, USA) and visualized after exposure to X-ray film.
###end p 62
###begin title 63
Electrophoretic mobility shift assays (EMSA)
###end title 63
###begin p 64
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 657 658 650 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W</italic>
###xml 659 660 652 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 777 778 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 966 967 956 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
Nuclear extracts were prepared from LNCaP cells using a nuclear extraction kit (Active Motif, Carlsbad, CA, USA) following the manufacturer's instructions. Oligonucleotides corresponding to the five binding sites shown in Table 2 were synthesized as probes. Equal amounts of sense and antisense oligonucleotides of NBSs were mixed and annealed in a buffer (10 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 mM EDTA) by heating to 95degreesC for 5 min and cooling slowly to room temperature. The five double-stranded NBSs were labelled with digoxigenin (DIG) (Roche). Binding reactions were performed for 20 min at room temperature in a 20 mul mixture containing 0.2% (W/V) Tween-20, 1 mM EDTA, 1 mM dithiothreitol, 30 mM KCl, 20 mM HEPES (pH 7.6), 1 mug of poly (dI-dC), 0.1 mug of poly (L-Lys), 20 mug of nuclear extract and 0.8 ng of DIG labelled double-stranded NBS. For the competition experiment, unlabelled double-stranded NBS or mutant NBS (sequences are shown in Table 2) in 250-fold excess were added to the binding reaction mixture and incubated. For supershift assays, anti-NKX3.1 antibody was pre-incubated with the nuclear extracts at room temperature for 30 min in the binding buffer, followed by an additional incubation for 20 min at room temperature with the reaction mixtures. Bound and free oligonucleotide probes were resolved by electrophoresis on an 8% nondenaturing polyacrylamide gel in 0.25 x Tris-Boric acid (TBE) buffer. Electroblotting and chemiluminescence detection were performed based on the instructions of the manufacturer of the DIG gel shift kit (Roche, Penzberg, Germany).
###end p 64
###begin title 65
Chromatin immunoprecipitation (ChIP)
###end title 65
###begin p 66
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 1661 1662 1641 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1718 1724 1698 1704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCAN1 </italic>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 799 805 <span type="species:ncbi:9986">rabbit</span>
In vivo binding of NKX3.1 to the NBSs in the upstream region of the PCAN1 gene was investigated using the ChIP assay kit (Upstate Biotechnology, Inc., Lake Placid, NY, USA). Confluent human LNCaP prostate cancer cells were transfected with pcDNA3.1-NKX3.1. Forty-eight hours after the transfection, cells were treated with formaldehyde (1% final concentration) to cross-link NKX3.1 to the DNA. Cells were washed with cold phosphate-buffered saline and lysed in SDS lysis buffer (1% SDS, 10 mM EDTA, and 50 mM Tris-HCl pH 8.1). The lysate was sonicated to shear DNA to a length between 200 and 1000 bp. The sonicated supernatant was diluted 10-fold with ChIP dilution buffer (0.01% SDS, 1% Triton X-100, 2 mM Tris-HCl pH 8.1), and 150 mM NaCl) and incubated with anti-NKX3.1 antibody (Santa Cruz) or rabbit IgG overnight at 4degreesC with rotation. To collect DNA/protein complexes, salmon sperm DNA/protein A-agarose slurry was added to the mixture and incubated for 1 h at 4degreesC with rotation, and the DNA/protein A-agarose was pelleted by centrifugation. After extensive washing of the pellet with a series of wash buffers, the pellet was dissolved with 250 mul of elution buffer and centrifuged to remove the agarose. The supernatant was treated with 20 mul of 5 M NaCl and heated to 65degreesC for 4 h to reverse the NKX3.1-DNA cross-link. After treatment with EDTA and proteinase K, the supernatant was extracted with phenol/chloroform and precipitated with ethanol to recover the DNA. For PCR using the chromatin-immunoprecipitated DNA, one-tenth of the DNA was PCR-amplified using four pairs of primers (primer names and sequences are shown in Table 1) that span the five NBSs in the upstream region of the PCAN1 gene respectively. Twenty-five cycles of PCR at 94degreesC for 30 s, 60degreesC for 30 s, and 72degreesC for 30 s were performed. PCR products were analyzed in 1% agarose gels.
###end p 66
###begin title 67
RNA interference (RNAi)
###end title 67
###begin p 68
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BamH </italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind </italic>
###xml 207 211 207 211 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GATC</underline>
###xml 207 212 207 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>GATC</underline>C</italic>
###xml 342 346 342 346 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TCGA</underline>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>TCGA</underline></italic>
###xml 360 364 360 364 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GATC</underline>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>GATC</underline>C</italic>
###xml 495 499 495 499 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TCGA</underline>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>TCGA</underline></italic>
###xml 513 517 513 517 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GATC</underline>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>GATC</underline>C</italic>
###xml 645 650 645 650 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TC GA</underline>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>TC GA</underline></italic>
###xml 757 761 757 761 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GATC</underline>
###xml 757 761 757 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>GATC</underline></italic>
###xml 894 898 894 898 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TCGA</underline>
###xml 894 898 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><underline>TCGA</underline></italic>
###xml 1135 1142 1135 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 715 720 <span type="species:ncbi:9606">human</span>
pRNAT-U6.1/Neo, containing human U6 promoter, was used to generate a series of RNAi expression vectors by inserting annealed oligonucleotides between BamH I and Hind III sites. The oligonucleotides RNAi1 (5'GATCCCCagttcagccatcagaagtaTT CAAGAGAtacttctgatggctgaactTTTTTGGAAA3' and 3'GGGtcaagtcggtagtcttcatAA GTTCTCTatgaagactaccgacttgaAAAAACCTTTTCGA5'), RNAi2 (5'GATCCCCtcca gaacagacgctataaTTCAAGAGAttatagcgtctgttctggaTTTTTGGAAA3' and 3'GGGagg tcttgtctgcgatattAAGTTCTCTaatatcgcagacaagacctAAAAACCTTTTCGA5'), RNAi3 (5'GATCCCCtataacagctatccttactTTCAAGAGAagtaaggatagctgttataTTTTTGGAAA3'and 3'GGGatattgtcgataggaatgaAAGTTCTCTtcattcctatcgacaatatAAAAACCTTTTC GA5') were used for the construction of pRNAT-RNAi (1~3) targeting human NKX3.1. The oligonucleotides RiN (5'GATCCCCttctccgaacgtgtcacgtTTCAAGAGA acgtgacacgttcggagaaTTTTTTGGAAA3' and 3' GGGaagaggcttgcacagtgcaAAGTTCT CTtgcactgtgcaagcctcttAAAAACCTTTTCGA5') were used for a control vector pRNAT-RiN producing a random sequence of RNAi. pRNAT-RNAi (1-3) and pRNAT-RiN were transfected into LNCaP cells, Forty-eight hours post-transfection, the cells were harvested to detect the silencing of NKX3.1 with RT-PCR and Western blot. The stable cell lines transfected with pRNAT-RNAi1 or pRNAT-RiN were selected with G418 (20 mug/ml) and individual clones were isolated.
###end p 68
###begin title 69
Authors' contributions
###end title 69
###begin p 70
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">WL </bold>
###xml 193 196 193 196 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PZ </bold>
###xml 404 407 404 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">WC </bold>
###xml 535 538 535 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CY </bold>
###xml 636 639 636 639 <bold xmlns:xlink="http://www.w3.org/1999/xlink">FC </bold>
###xml 712 715 712 715 <bold xmlns:xlink="http://www.w3.org/1999/xlink">FK </bold>
###xml 793 796 793 796 <bold xmlns:xlink="http://www.w3.org/1999/xlink">JZ </bold>
###xml 883 886 883 886 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AJ </bold>
WL assisted in the design of the study, carried out the cloning of expression vectors and reporter plasmid constructs, transfection studies, RT-PCR, EMSA and ChIP; helped draft the manuscript. PZ assisted in the design of the study, participated in the sequence alignment and use of computer database; assisted in the construction of recombinant vectors, EMSA, ChIP and RNAi; helped draft the manuscript.WC participated in maintenance of cell lines, performed luciferase reporter assays and assisted with the transfection experiments. CY carried out the isolation of RNA and purification of plasmids, assisted with the RT-PCR and ChIP. FC carried out Western blot and assisted with the purification of plasmids. FK assisted with the maintenance of cell lines and the transfection experiments. JZ participated in the design of the study, assisted with the revising of the manuscript. AJ participated in the design of the study and revision of the manuscript, helped draft the manuscript, assisted with the construction of recombinant vectors, EMSA and ChIP.
###end p 70
###begin p 71
All authors have read and approved the final manuscript.
###end p 71
###begin title 72
Acknowledgements
###end title 72
###begin p 73
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1 </italic>
The authors are grateful to Dr. Charles Young for kindly providing pCR2.1-NKX3.1 plasmid used in this study. This work was supported by Natural Science Foundation of Shandong Province (No. Y2007C96) and the National Natural Science Foundation of China (No.30470952 and No.30670581).
###end p 73
###begin article-title 74
Cancer statistics, 2006
###end article-title 74
###begin article-title 75
Therapeutic approach to hormone-refractory prostate cancer
###end article-title 75
###begin article-title 76
Hormone refractory prostate cancer (HRPC): present and future approaches of therapy
###end article-title 76
###begin article-title 77
Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines
###end article-title 77
###begin article-title 78
Identification of a gene frequently mutated in prostate tumors
###end article-title 78
###begin article-title 79
GDEP, a new gene differentially expressed in normal prostate and prostate cancer
###end article-title 79
###begin article-title 80
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx </italic>
###xml 30 36 <span type="species:ncbi:10090">murine</span>
Tissue-specific expression of murine Nkx 3.1 in the male urogenital system
###end article-title 80
###begin article-title 81
Prostate-specific and androgen dependent expression of a novel homeobox gene
###end article-title 81
###begin article-title 82
Roles for Nkx3.1 in prostate cancer development and cancer
###end article-title 82
###begin article-title 83
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx3.1 </italic>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia
###end article-title 83
###begin article-title 84
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NKX3.1</italic>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers
###end article-title 84
###begin article-title 85
Chromosomal deletions and tumor suppressor genes in prostate cancer
###end article-title 85
###begin article-title 86
Up-regulation of NKX3.1 expression and inhibition of LNCaP cell proliferation induced by an inhibitory element decoy
###end article-title 86
###begin article-title 87
###xml 34 39 <span type="species:ncbi:9606">human</span>
Effects of 9-cis retinoic acid on human homeobox gene NKX3.1 expression in prostate cancer cell line LNCaP
###end article-title 87
###begin article-title 88
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis
###end article-title 88
###begin article-title 89
###xml 38 43 <span type="species:ncbi:9606">human</span>
Molecular cloning and analysis of the human PCAN1 (GDEP) promoter
###end article-title 89
###begin article-title 90
###xml 29 34 <span type="species:ncbi:9606">human</span>
Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression
###end article-title 90
###begin article-title 91
Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor
###end article-title 91
###begin article-title 92
Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells
###end article-title 92
###begin article-title 93
Structural and functional analysis of domains mediating interaction between NKX-3.1 and PDEF
###end article-title 93
###begin article-title 94
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nkx3.1 </italic>
Haploinsufficiency at the Nkx3.1 locus A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation
###end article-title 94
###begin article-title 95
###xml 51 56 <span type="species:ncbi:9606">human</span>
Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis
###end article-title 95
###begin article-title 96
###xml 28 33 <span type="species:ncbi:9606">human</span>
DNA-binding sequence of the human prostate-specific homeodomain protein NKX3.1
###end article-title 96
###begin article-title 97
Groucho-mediated transcriptional repression establishes progenitor cell pattern and neuronal fatein the ventral neural tube
###end article-title 97
###begin article-title 98
The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription
###end article-title 98
###begin article-title 99
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
The smooth muscle gamma-actin gene promoter is a molecular target for the mouse bagpipe homologue, mNkx3-1, and serum response factor
###end article-title 99
###begin article-title 100
A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes
###end article-title 100

